OnDemand WTP Pricing Research

Tag: Price Gouging

GoodRX: App has saved Americans more than $10 billion on prescriptions | CNBC

GoodRX: App has saved Americans more than $10 billion on prescriptions | CNBC

Back in 2010 Doug Hirsch, a techie who has worked at Facebook and Yahoo, had a frustrating experience trying to pick up a prescription. He went to a big chain pharmacy in Los Angeles and was told — to his dismay — that his prescription would cost $450. An experienced shopper, Hirsch decided to do […]

Texas Moves to Bring Clarity to Drug Pricing | Public News Service

Texas Moves to Bring Clarity to Drug Pricing | Public News Service

Will more transparency about drug pricing help drive down costs for Texas consumers, or add expenses for the drug companies that have to comply? (Gang/Adobe Stock) AUSTIN, Texas – Texas lawmakers are showing overwhelming support so far for legislation that AARP says would be one of the strongest drug-price transparency measures in the country. House […]

The Price of Price Controls: Innovation Likely to Suffer in Drug Pricing Debate | IPWatchDog

The Price of Price Controls: Innovation Likely to Suffer in Drug Pricing Debate | IPWatchDog

The Cost of Cheap The reason drugs are cheaper in other countries is because those other countries have price controls. If pharmaceutical companies want to sell into those countries, they have to charge those low prices. And if the required low price is set above the marginal cost to produce the drug, then the pharmaceutical […]

The Competition Bureau is Wide Awake: Hudson’s Bay Company to Pay $4.5 Million for Deceptive Advertising and Pricing Practices of its Sleep Sets | Lexology

The Competition Bureau is Wide Awake: Hudson’s Bay Company to Pay $4.5 Million for Deceptive Advertising and Pricing Practices of its Sleep Sets | Lexology

Hudson’s Bay Company has agreed to pay an administrative monetary penalty of $4,000,000 and $500,000 towards Competition Bureau costs to resolve a proceeding which started in 2017 relating to Hudson’s Bay Company advertising and pricing practices for its sleep sets The Competition Bureau (“Bureau”) initially took legal action against Hudson’s Bay Company (“HBC”) in 2017, […]

Buy Coca-Cola Stock for Its ‘Clearly Superior Growth’ | Barron’s

Buy Coca-Cola Stock for Its ‘Clearly Superior Growth’ | Barron’s

What’s new. Morgan Stanley analyst Dara Mohsenian raised his rating on Coke to Overweight from Equal Weight, and added $3 to his price target, to $55. He argues that Coke “offers a clearly superior growth outlook versus consumer packaged goods peers, with stronger pricing power, favorable strategy tweaks, solid volume growth, and rebounding emerging market […]

A new study sparks a war of words over pharma’s commitment to research | STAT

A new study sparks a war of words over pharma’s commitment to research | STAT

WASHINGTON — A coalition of the drug industry’s fiercest foes is accusing the world’s top drug makers of hiding behind research and development “as an excuse for price-gouging American patients.” And they’re pointing to a new study that finds drug makers spent about 22% of their revenues on research and development in 2017 to prove […]

Drug court to try firms refusing to cut prices | The Express Tribune

Drug court to try firms refusing to cut prices | The Express Tribune

ISLAMABAD: The government is expected to take up the issue of hike in drug prices at its next cabinet meeting while it intends to move the drug court against all those pharmaceutical companies who refuse to lower prices of their medicines in line with the recent policy decision of the government. This was disclosed by the […]

Pharma stocks crash after US lawsuit over price manipulations | The Economic Times

Pharma stocks crash after US lawsuit over price manipulations | The Economic Times

The office of the attorney general of Connecticut unsealed documents, that ET has a copy of, which reveals initials and titles of individuals implicated in the conspiracy, industry “code words” and previously undisclosed emails from drug companies “brazenly discussing strategy to violate federal and state antitrust laws”. The Indian generic makers named in the lawsuit […]

Beshear Files Claim Against Drug Manufacturers for alleged Price Gouging | SurfKY News

Beshear Files Claim Against Drug Manufacturers for alleged Price Gouging | SurfKY News

FRANKFORT, Ky. (5/13/19) — Attorney General Andy Beshear filed two lawsuits seeking to recover ill-gotten gains from 23 drug manufacturers that skyrocketed the prices of more than 100 prescription drugs including those used to treat diabetes, epilepsy and cancer. In Franklin Circuit Court, Beshear filed suit against three of the largest insulin manufacturers, Eli Lilly, […]

The UK’s new medicines pricing deal – opportunities and risks for pharma | PMLiVE

The UK’s new medicines pricing deal – opportunities and risks for pharma | PMLiVE

January 2019 saw the introduction of the new Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) in the UK. There are some significant changes, and the complexity of the deal can make it bewildering. So what does it mean for pharma, and what can the sector do to maximise its opportunities and minimise its […]